Drug intelligence / Profile preview

AAC2-insulin

Development stage
Preclinical
Lead developer
The Ohio State University
Modality
Modified Peptides → Peptides, Peptide Conjugates → Peptides, Recombinant Proteins and Enzymes
Administration
Intraperitoneal
01

Overview

AAC2-insulin is an experimental **AAC2-human insulin complex** in which human insulin is adsorbed onto positively charged self-assembling AAC2 dipeptide nanofibers. AAC2 provides insulin-independent metabolic activity through leptin receptor-associated signaling, while the insulin component activates insulin receptor signaling; the nanofiber complex is intended to improve insulin exposure and glucose regulation while reducing hypoglycemia. In mouse models of type 1 diabetes and early Alzheimer’s disease-related pathology, AAC2-hINS improved circulating and brain insulin exposure, glycemic and cognitive outcomes, and survival relative to free insulin in reported experiments. It remains an academic, preclinical research program without a marketed product or assigned INN. ([mdpi.com](https://www.mdpi.com/1999-4923/14/1/81))

Other names
AAC2 + hINSAAC2-bound human insulinAAC-2-bound human insulinAAC 2-bound human insulinAAC2-hINSAAC-2-hINSAAC 2-hINSAAC2-insulinAAC-2-insulinAAC 2-insulin
02

Targets

INSR (Insulin receptor)Amino acid compound 2 (AAC2)–human insulin (hINS) nanofiber–receptor complexLEPR (Leptin receptor)

Beyond the preview

Go deeper on AAC2-insulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AAC2-insulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call